Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Guardant Health Inc. Common Stock (GH) vs Northrop Grumman Corporation (NOC) Price & Performance

Guardant Health Inc. Common StockTrade
Northrop Grumman CorporationTrade

Price performance (Past 24H)

Key statistics

Guardant Health Inc. Common Stock vs Northrop Grumman Corporation — how do they compare? Guardant Health Inc. Common Stock trades at $167.29 (market cap $22.22B), while Northrop Grumman Corporation trades at $480.06 (market cap $68.83B). The key difference: Northrop Grumman Corporation is far larger — about 3.1× Guardant Health Inc. Common Stock's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and Northrop Grumman Corporation for 81 Days on average.

GHNOC
Market Cap
$22.22B$68.83B
Volume
1,589,4531,081,989
Sector
HealthIndustrials
52-Week High
$187.22$768.02
52-Week Low
$61.73$473.46
Typical Hold Time
1 Days81 Days
Enterprise Value
$22.86B$82.81B
Dividend Yield
—2.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Guardant Health Inc. Common Stock

No Aura AI signal available yet.

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $480.85, up 1.56% with recent earnings beats but faces technical bearish signals. The company maintains strong fundamentals with $41.95B revenue, 10.48% net margin, and attractive valuation at 15.4 P/E. Recent news highlights both contract wins and competitive losses, including Boeing's $20B Navy fighter award.

Outlook remains positive with analyst consensus at $600.62 target (25% upside) and 54% buy ratings. Key risks include defense contract volatility and competitive pressures, while strong backlog ($104.7B) and dividend growth support long-term value. The stock offers defensive exposure to elevated defense spending cycles.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Guardant Health Inc. Common Stock

Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.

Read more on GH →

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC →